These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16763275)

  • 61. concomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical study.
    Strojan P; Karner K; Smid L; Soba E; Fajdiga I; Jancar B; Anicin A; Budihna M; Zakotnik B
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):365-72. PubMed ID: 18394816
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy.
    Mencoboni M; Grillo-Ruggieri F; Salami A; Scasso F; Rebella L; Grimaldi A; Dellepiane M; Moratti G; Bruzzone A; Spigno F; Ghio R; Figliomeni M
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):503-7. PubMed ID: 20477856
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
    Chufal KS; Rastogi M; Srivastava M; Pant MC; Bhatt ML; Srivastava K
    Jpn J Clin Oncol; 2006 Sep; 36(9):537-46. PubMed ID: 16905755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial.
    Rasch CR; Hauptmann M; Schornagel J; Wijers O; Buter J; Gregor T; Wiggenraad R; de Boer JP; Ackerstaff AH; Kroger R; Hoebers FJ; Balm AJ; Hilgers FJ
    Cancer; 2010 May; 116(9):2159-65. PubMed ID: 20187094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Current status and future directions in induction chemotherapy for head and neck cancer.
    Argiris A
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):57-74. PubMed ID: 23541071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Role and interest of induction chemotherapy for head and neck cancers].
    Pointreau Y; Schick U; Huguet F
    Cancer Radiother; 2017 Oct; 21(6-7):505-509. PubMed ID: 28865969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
    Brockstein B; Haraf DJ; Rademaker AW; Kies MS; Stenson KM; Rosen F; Mittal BB; Pelzer H; Fung BB; Witt ME; Wenig B; Portugal L; Weichselbaum RW; Vokes EE
    Ann Oncol; 2004 Aug; 15(8):1179-86. PubMed ID: 15277256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects.
    Chandana SR; Conley BA
    Curr Opin Oncol; 2009 May; 21(3):218-23. PubMed ID: 19370805
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer: an alternative?
    Merlano M
    Oncologist; 2006 Feb; 11(2):146-51. PubMed ID: 16476835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction chemotherapy for head and neck cancer: will history repeat itself?
    Argiris A
    J Natl Compr Canc Netw; 2005 May; 3(3):393-403. PubMed ID: 16002005
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.
    Hao D; Ritter MA; Oliver T; Browman GP
    Semin Radiat Oncol; 2006 Jan; 16(1):10-9. PubMed ID: 16378902
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of chemotherapy for skull base carcinomas and sarcomas.
    Adelstein DJ
    Neurosurg Clin N Am; 2000 Oct; 11(4):681-91. PubMed ID: 11082178
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1992 Jun; 4(3):504-11. PubMed ID: 1498159
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reassessment of the role of induction chemotherapy for head and neck cancer.
    Gibson MK; Forastiere AA
    Lancet Oncol; 2006 Jul; 7(7):565-74. PubMed ID: 16814208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Organ preservation trials for laryngeal cancer.
    Gilbert J; Forastiere AA
    Otolaryngol Clin North Am; 2002 Oct; 35(5):1035-54, vi. PubMed ID: 12587246
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [In reference to the article: "Neck dissection following chemoradiation for node positive head and neck carcinomas" by Thariat et al. Cancer Radiother 2009;13:758-770].
    Maillard S; Merol JC; Chays A; Nguyen TD
    Cancer Radiother; 2010 Jun; 14(3):222; author reply 222-4. PubMed ID: 20189432
    [No Abstract]   [Full Text] [Related]  

  • 80. [Chemo-radiotherapy for head and neck cancer].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2002 May; 29(5):677-83. PubMed ID: 12040670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.